Key facts
- It has raised $190.8M; the latest was PE Growth/Expansion ($53.9M) in Sep 2024.
- Notable investors include Endeavor Catalyst, MSD Global Health Innovation Fund, Escalate Capital Partners, NewSpring Capital, North Sky Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for AeroSafe Global
- ·The full record, as it builds
Funding rounds
No funding rounds for AeroSafe Global are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AeroSafe Global
Provider of outsourced cold chain management services intended to serve the pharmaceutical, biopharmaceutical, specialty pharmacy, and medical device companies. The company specializes in offering supply chain via packaging technology re-use business model, data tracking, and analytics, helping its clients with safe and sustainable delivery of temperature-sensitive drugs and devices.
- Sector
- Business Products and Services (B2B)
- HQ
- Rochester, NY, United States
- Founded
- 1995
- Employees
- 112
- Website
- aerosafeglobal.com/
- Ownership
- Privately Held (backing)
AeroSafe Global doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AeroSafe Global shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AeroSafe Global in its N-PORT filings yet. We sweep new filings monthly.